Release Notes:
Data Element
Version 2016B1
| Data Element Name: | Aldosterone Receptor Antagonist Prescribed for LVSD in the Outpatient Setting |
|---|
| Collected For: | ACHFOP-03, |
|---|
| Definition: | Documentation that aldosterone receptor antagonist was prescribed for LVSD in the outpatient setting. The main action of aldosterone is to increase sodium re-absorption by the kidneys. At the same time it increases the excretion of hydrogen and potassium ions. Aldosterone receptor antagonists block the effects of aldosterone, therefore decreasing sodium re-absorption and water retention by the kidneys and consequently lead to a decrease in blood pressure. Aldosterone receptor antagonists are used to treat hypertension. |
|---|
| Suggested Data Collection Question: | Was an aldosterone receptor antagonist prescribed for LVSD in the outpatient setting? |
|---|
| Format: | | Length: | 1 |
|---|
| Type: | Alphanumeric |
|---|
| Occurs: | 1 |
|---|
|
|---|
| Allowable Values: |
Y (Yes) An aldosterone receptor antagonist was prescribed for LVSD in the outpatient setting, or the patient is currently on this medication.
N (No) An aldosterone receptor antagonist was not prescribed for LVSD in the outpatient setting or unable to determine from medical record documentation.
|
|---|
| Notes for Abstraction: |
- All medication documentation available in the chart should be reviewed and taken into account by the abstractor.
- If the patient is currently on an aldosterone receptor antagonist, answer Yes.
- If the patient does not have LVSD or an ejection fraction <40%, select "No".
|
|---|
| Suggested Data Sources: |
- Discharge summary
- Discharge instruction sheet
- Outpatient medical record
|
|---|
| Additional Notes: |
|
|---|
| Guidelines for Abstraction: |
|---|
| Inclusion | Exclusion |
- Spironolactone
- Eplerenone
|
All other aldosterone receptor antagonist medications other than those listed as inclusions. |
|
Aldosterone Receptor Antagonist Prescribed for LVSD in the Outpatient Setting
Specifications Manual for Joint Commission National Quality Measures (v2016B1)
Discharges 01-01-17 (1Q17) through 06-30-17 (2Q17)
^
Warning: your browser isn't supported. Please install a modern one, like Firefox, Opera, Safari, Chrome or the latest Internet Explorer.
Thank you!